$0.37 +0.01 (2.62%) Peregrine Pharmaceuticals Inc - NASDAQ

Aug. 29, 2016 | 03:59 PM
Last Trade: 0.37
Trade Time: Aug 29 03:59 PM Eastern Daylight Time
Change: +0.01 (2.62%)
Prev Close: 0.36
Open: 0.36
Bid: 0.37
Ask: 0.37
  1. No results found.
  1. Peregrine Pharmaceuticals and National Comprehensive Cancer Network (NCCN) Form Clinical Collaboration to Evaluate Novel Cancer Treatment Combinations With Bavituximab

    Benzinga | Jan. 6, 2016 | 08:12AM EST
  2. New Preclinical Data Presented at SITC Annual Meeting Highlight Bavituximab's Enhanced Anti-Tumor Activity When Combined With Checkpoint Inhibitors in Breast Cancer and Melanoma

    Benzinga | Nov. 9, 2015 | 08:05AM EST
  3. New Translational Data Highlights Bavituximab's Ability to Induce Signs of Immune Activation in Lung Cancer Tumor Samples With Negative PD-L1 Expression

    Benzinga | Sep. 8, 2015 | 08:17AM EST
  4. US Stock Futures Tumble, China's Shanghai Plunges 8.5%

    Benzinga | Aug. 24, 2015 | 07:28AM EST
  5. AstraZeneca, Peregrine Pharmaceuticals to Collaborate on Immuno-Oncology Combination Clinical Trial

    Benzinga | Aug. 24, 2015 | 04:27AM EST
  6. Peregrine Pharmaceuticals Granted Key European Patent for Its Lead Clinical Drug Candidate Bavituximab

    Benzinga | Jun. 25, 2015 | 08:30AM EST
  7. Peregrine Pharmaceuticals Announces Three Abstracts Accepted for Presentation at AACR 2015 Annual Meeting

    Benzinga | Apr. 14, 2015 | 08:02AM EST
  8. Morning Market Gainers

    Benzinga | Feb. 9, 2015 | 09:48AM EST
  9. Monday Morning Movers: Achillion Up, Regulus Down Following Drug Results

    Benzinga | Feb. 9, 2015 | 09:05AM EST
  10. Phase II Clinical Data of Peregrine Pharmaceuticals' Bavituximab in Combination With Sorafenib ...

    GuruFocus | Jan. 16, 2015 | 11:02AM EST
  11. Data to Be Presented at 2014 San Antonio Breast Cancer Symposium Demonstrate Immune-Stimulatory ...

    GuruFocus | Dec. 12, 2014 | 11:03AM EST
  12. Avid Bioservices Announces Expansion of cGMP Manufacturing Capacity

    GuruFocus | Dec. 10, 2014 | 11:04AM EST
  13. Avid Bioservices Announces Expansion Of cGMP Manufacturing Capacity

    Benzinga | Dec. 10, 2014 | 08:09AM EST
  14. Earnings Scheduled For December 10, 2014

    Benzinga | Dec. 10, 2014 | 04:53AM EST
  15. Phase II Clinical Data Presented at SITC Annual Meeting Support Immunotherapeutic Mechanism of ...

    GuruFocus | Nov. 10, 2014 | 11:02AM EST
Trading Center